EXEL: Citizens Raises Target
Citizens maintains Market Outperform on Exelixis and raises price target to $55
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Citizens maintains Market Outperform on Exelixis and raises price target to $55
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.